(K.Sugiyama, K.Omachi, K.Fujiwara, T.Saotome, N.Mizunuma, S.Takahashi, Y.Ito, Keisuke Aiba, N.Horikoshi)Irinotecan hydrochroride for the treatment of recurrent and refractory Non-Hodgkin Lymphoma. A single institution experience Cancer. 2002. 94:594-600
Y.Ito Chemotherapy and hormone therapy for breast cancer:Current status and perspective. JMAJ. 2002. 45:424-433